Risk/Benefit Of CAR-T For Autoimmune Diseases May Shift With FDA Investigation

Use Could Be Restricted To Most Severe Patients

3d illustration of cytotoxic CAR exosomes secreted by engineered T immune cells
CAR-T use in autoimmune diseases is just beginning • Source: Shutterstock

More from Immuno-oncology

More from Anticancer